Poster Presentations Session V
Poster Presentations Session V Wednesday, May 23, 2018
POSTERS SET-UP: 8:15 AM - 8:30 AM
POSTERS DISPLAY HOURS: 8:30 AM - 1:30 PM
POSTER AUTHOR DISCUSSION: 12:30 PM - 1:30 PM
POSTERS DISMANTLE: 1:30 PM


Poster display locations are shown below the poster codes
MEDICAL DEVICES/DIAGNOSTICS - Clinical Outcomes Studies
PMD1
A1
USE OF VASCULAR CLOSURE DEVICES IN THE HOSPITAL SETTING FOR PERCUTANOUS CORONARY PROCEDURES AND GENDER DIFFERENCES OF THE MYNX® VASCULAR CLOSURE DEVICE: RESULTS FROM A HOSPITAL CLAIMS ANALYSIS
Mallow P1, Belk K2, Craver CW2, Almedhychy A3
1Xavier University, Cincinnati, OH, USA, 2Vizient Inc., Mooresville, NC, USA, 3Cardinal Health, Milpitas, CA, USA

PMD2
A2
THE BURDEN OF SICKLE CELL DISEASE
Dierick K
Terumo BCT, Zaventem, Belgium

PMD3
A3
A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS OF COMPLICATIONS POTENTIALLY ASSOCIATED WITH SINGLE INCISION SLINGS (SIS) FOR THE TREATMENT OF STRESS URINARY INCONTINENCE
Lu X, Du D, Loyo-Berrios N, Cunkelman J, O'Neill A, Marinac-Dabic D
U.S. Food and Drug Administration, Silver Spring, MD, USA

PMD4
A4
COST-EFFECTIVENESS ANALYSIS OF HIGH-SENSITIVITY TROPONIN T VERSUS CONVENTIONAL TROPONIN I TESTING FOR ACUTE MYOCARDIAL INFARCTION
Hsu W1, Galm B1, Hsu S2, Lee C3
1Harvard University, Boston, MA, USA, 2Tunghai University, Taichung, Taiwan, 3National Taiwan University Hospital, Taipei, Taiwan

PMD5
A5
WITHDRAWN

PMD6
A6
REAL-WORLD DATA ANALYSIS OF CONFIRMATORY BIOPSY UTILIZATION IN SUSPECTED PROSTATE CANCER PATIENTS
Scott J, Concepcion R, Garofalo D, Verma-Kurvari S, Xu B, Montgomery J
Integra Connect, West Palm Beach, FL, USA

PMD7
A7
BIOPSY PROCEDURES IN PATIENTS WITH PRIMARY LUNG CANCER
Zhang Y1, Lavin J2, Liu E2, Shi L1
1Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA, 2Intuitive Surgical, Sunnyvale, CA, USA

PMD8
A8
SERUM AUTOANTIBODIES MULTI-TESTING IN RHEUMATOID ARTHRITIS IN PRIMARY CARE CAN REDUCE AVOIDABLE COSTS ASSOCIATED TO FALSE POSITIVES. A SIMULATION STUDY IN THE UNITED STATES OF AMERICA
Mascialino B1, Swiniarski S2, Gehring I2, Poorafshar M1, Tarrant T3
1Thermo Fisher Scientific, Uppsala, Sweden, 2Thermo Fisher Scientific, Freiburg, Germany, 3Duke School of Medicine, Durham, NC, USA

PMD9
A9
WITHDRAWN

PMD10
A10
THE RELATIONSHIP BETWEEN COMPLIANCE AND BLINDNESS PREVENTION IN ECONOMIC MODELS FOR DIABETIC RETINOPATHY SCREENING
Herring W, Gould IG, Zhang Y, Mladsi DM
RTI Health Solutions, Research Triangle Park, NC, USA

PMD11
A11
HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) IS NOT “THE FEMALE ERECTILE DYSFUNCTION (ED)”: CHALLENGES WITH THE CHARACTERIZATION OF HSDD IN WOMEN
Kingsberg S1, Al-Khateeb Z2, Karkare S2, Hadker N2, Lim-Watson M3
1University Hospitals Cleveland Medical Center, Cleveland, OH, USA, 2Trinity Partners, Waltham, MA, USA, 3AMAG Pharmaceuticals, Inc., Waltham, MA, USA

PMD12
A12
WITHDRAWN

PMD13
A13
A CANADIAN COST-UTILITY ANALYSIS OF TWO TRABECULAR MICRO-BYPASS STENTS IN PATIENTS WITH MILD-TO-MODERATE OPEN-ANGLE GLAUCOMA
Ahmed II1, Goeree R2, Patel V3, Murray J4, Falvey H5, Podbielski DW1
1Prism Eye Institute, Mississauga, ON, Canada, 2Professor Emeritus, McMaster University and Goeree Consulting Ltd, Hamilton, ON, Canada, 3Pharmerit International, Bethesda, MD, USA, 4Glaukos Corp, Richmond Hill, ON, Canada, 5Glaukos Corp, San Clemente, CA, USA

PMD14
A14
COMPARATIVE EFFECTIVENESS OF A BILAYERED LIVING CELLULAR CONSTRUCT AND AN ACELLULAR FETAL BOVINE COLLAGEN DRESSING IN THE TREATMENT OF VENOUS LEG ULCERS
Sabolinski M
Sabolinski LLC., Franklin, MA, USA

PMD15
A15
BENEFITS OF A HEART-SHAPED SUTURING TECHNIQUE IN CESAROTOMY CLOSURE: EXPERIENCE FROM AN ACADEMIC MEDICAL CENTER IN CHINA
Wang Y1, Shang M1, Zhou Y1, Li J1, Wu Z1, Li X1, Ran J1, Yang F2, Feng W3, Xuan J4
1The First Affiliated Hospital of Xiamen University, Xiamen, China, 2Shanghai Centennial Scientific Ltd, Shanghai, China, 3Institute of Pharmaceutical Economics, Sun Yat - sen University, guangzhou, China, 4Sun Yat-sen University, Guangzhou, China

PMD16
A16
ARE ALL ENDOSCOPIC SURGICAL STAPLERS THE SAME? FINDINGS FROM A REAL-WORLD ASSESSMENT IN BARIATRIC PROCEDURES
Roy S1, Yadalam S2, Johnston SS3
1Ethicon Inc, Somerville, NJ, USA, 2Johnson & Johnson Co., New Brunswick, NJ, USA, 3Johnson & Johnson, Inc., New Brunswick, NJ, USA

PMD17
A17
IMPACT OF V-GO VERSUS MULTIPLE DAILY INJECTIONS ON GLYCEMIC CONTROL, INSULIN UTILIZATION AND HEALTHCARE COSTS AMONG INDIVIDUALS WITH TYPE 2 DIABETES MELLITUS
Raval A1, Nguyen M2, Zhou S1, Grabner M1, Barron J1, Quimbo R1
1HealthCore, Inc., Wilmington, DE, USA, 2Valeritas, Inc., Bridgewater, NJ, USA

PMD18
A18
VASCULAR ACCESS OUTCOMES: IMPACT ON QUALITY OF LIFE AND ASSOCIATED COSTS FOLLOWING SURGICAL OR ENDOVASCULAR ARTERIOVENOUS FISTULA CREATION FOR HEMODIALYSIS PATIENTS
Yu TM, Tang J, Tradonsky AN, Arnold RJ
Navigant Consulting, Inc., San Francisco, CA, USA

PMD19
A19
PROVISIONAL VERSUS COMPLEX OR TRYTON STENTING STRATEGIES FOR SIGNIFICANT BIFURCATED LESIONS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A SYSTEMATIC REVIEW
Parsley L, Brandt DM, Carr DL, Alexander ES, Mallow P
Xavier University, Cincinnati, OH, USA

PMD20
A20
A SYSTEMATIC REVIEW OF CLINICAL EFFICACY ASSOCIATED WITH USE OF PROTEASE-MODULATING INTERVENTIONS WITH DIABETIC FOOT ULCER OR VENOUS LEG ULCER
Yeowell G, Betts A, Odeyemi I, Fatoye F
Manchester Metropolitan University, Manchester, UK

PMD21
A21
HOSPITAL RELATED CLINICAL AND ECONOMICAL OUTCOMES OF A BICRUCIATE KNEE SYSTEM IN TOTAL KNEE ARTHROPLASTY PATIENTS
Mayman DJ1, Patel AR2, Carroll KM1
1Hospital for Special Surgery, New York, NY, USA, 2Smith & Nephew Inc, Fort-worth, TX, USA

PMD22
A22
COMPARISON OF ECONOMIC AND CLINICAL OUTCOMES BETWEEN SKIN STAPLES PLUS WOUND DRESSINGS AND 2-OCTYL CYANOACRYLATE PLUS POLYMER MESH TAPE AMONG PATIENTS UNDERGOING CESAREAN SECTION
Johnston SS1, Geethu R2, Costa M2, Lee SH3, Schmitz N4, Chen BP5
1Johnson & Johnson, Inc., New Brunswick, NJ, USA, 2Johnson & Johnson, North Sydney NSW, Australia, 3Johnson & Johnson Medical, Asia Pacific, Singapore, Singapore, 4Ethicon, Johnson & Johnson, Somerville, NJ, USA, 5Ethicon Inc, Somerville, NJ, USA

PMD23
A23
COMPARATIVE ANALYSIS INVESTIGATING THE IMPACT OF IMPLANT DESIGN ON HOSPITAL LENGTH OF STAY AND DISCHARGE DESTINATION IN A DUTCH HOSPITAL WITH AN ESTABLISHED ENHANCED RECOVERY PROGRAM
Meermans G1, Galvain T2, Wigham R3, Do Rego B4, Schroer D5
1Bravis Hosptal, Bergen op Zoom, The Netherlands, 2Johnson & Johnson Medical SAS, Issy les Moulineaux, France, 3Johnson & Johnson Medical Limited, Livingston, West Lothian, UK, 4DePuy Synthes, Leeds, West Yorkshire, UK, 5Johnson & Johnson Medical, Amersfoort, The Netherlands

PMD24
A24
WITHDRAWN

PMD25
A25
WITHDRAWN

PMD26
A26
IMPROVED QUALITY CONTROL WITH SUBCUTANEOUS (SC) INFUSION PUMP
Lukács M1, Oláh A1, Boncz I1, Csikós Á1, Busa C1, Frank N1, Endrei D1, Pakai A2
1University of Pécs, Pécs, Hungary, 2University of Pécs, Zalaegerszeg, Hungary

PMD27
A27
EFFICIENCY OF THE USE OF LONG-ACTING REVERSIBLE CONTRACEPTION: A SYSTEMATIC REVIEW OF THE LITERATURE
Gomez de la Rosa F1, Alvis Zakzuk J2, Alvis Guzman N3, Moreno DJ4, Rincon M5, Vargas JC6, Edna Estrada F7, Urrego M8, Rubio ML9, Alvarez Mesa C8, Tolosa J5
1ALZAK Foundation, Cartagena, Colombia, 2ALZAK Foundation, Centro de investigación Seguridad Materna - Grupo de investigacion para la salud materna, perinatal y de la mujer - Clínica Maternidad Rafael Calvo, CARTAGENA, Colombia, 3Universidad de Cartagena - ALZAK Foundation, Cartagena, Colombia, 4Ministerio de Salud y protección Colombia, Bogota, Colombia, 5Oregon Health & Science University, Portland, OR, USA, 6Profamilia Colombia, Bogota, Colombia, 7Centro de Investigación para la Salud Materna Perinatal y de la Mujer. Clinica Maternidad Rafael Calvo C., Cartagena de Indias, Colombia, 8Universidad de Antioquia, Medellín, Colombia, 9UNFPA, Bogota, Colombia

MEDICAL DEVICES/DIAGNOSTICS - Cost Studies
PMD28
A28
BUDGET IMPACT ANALYSIS OF THE ADVANCE LUBRICATH® FOLEY CATHETER TRAY® FOR URINARY CATHETERIZATION OF LONG DURATION IN MEXICO
Ruiz Miranda CI1, Rodriguez Mendoza MM2, Goméz Zamesa M1, Sanchez Trejo K2
1Becton Dickinson, Mexico City, Mexico, 2Consultoría en Investigación Farmacéutica, Mexico State, Mexico

PMD29
A29
BUDGET IMPACT ANALYSIS (BIA) OF POINT-OF-CARE OF HBA1C MONITORING IN BELGIAN, GERMAN AND SWISS PATIENTS WITH DIABETES MELLITUS TYPE II
Navarro F1, Hren R2, Boltyenkov A3
1Siemens Healthcare Diagnostics Inc., Norwood, MA, USA, 2University of Ljubljana, Ljubljana, Slovenia, 3Siemens Healthcare GmbH, Erlangen, Germany

PMD30
A30
ECONOMIC ANALYSIS OF D-DIMER TEST USED FOR THE DIAGNOSIS OF VENOUS THROMBOEMBOLISM IN COLOMBIA
Galvez K1, Robles A2, Tamayo C3, Simbaqueba E4
1Hospital Pablo Tobón Uribe, Medellin, Colombia, 2Universidad de Alicante, Alicante, Spain, 3U Nacional, Bogota, Colombia, 4Werfen, Bogota, Colombia

PMD31
A31
BUDGET IMPACT ANALYSIS OF IMPLEMENTING 5MM DUAL-ENDED SAFETY PEN NEEDLES FOR INSULIN INJECTIONS IN US HOSPITALS
Ermakova A, Taylor S
Becton Dickinson, Franklin Lakes, NJ, USA

PMD32
A32
HEALTH ECONOMIC MODEL FOR ESTIMATING THE DIRECT COST IMPACT OF ADOPTING A VASCULAR ACCESS ANTIMICROBIAL BUNDLE OF SOLUTIONS IN ICU SETTINGS IN GERMANY
Palka-Santini M1, Topachevskyi O2
13M Deutschland GmbH, Neuss, Germany, 2Digital Health Outcomes, Brussels, Belgium

PMD33
A33
BUDGET IMPACT ANALYSIS OF A NOVEL ALTERNATING PRESSURE SUPPORT SURFACE IN THE ACUTE CARE SETTING
Hayashi DE1, Kill T2, Fitzpatrick MA2, Gutzwiller L2, Dzioba DA2, Peyerl FW1
1Boston Strategic Partners, Inc., Boston, MA, USA, 2Dabir Surfaces Inc., Harwood Heights, IL, USA

PMD34
A34
ARE SINGLE-PATIENT USE ELECTROCARDIOGRAPH CABLE AND LEAD SYSTEMS DURING CORONARY ARTERY BYPASS GRAFT MONITORING A BENEFIT TO HEALTHCARE PAYERS: A BUDGET IMPACT ANALYSIS
Saunders R1, Lankiewicz J2
1Coreva Scientific, Freiburg im Breisgau, Germany, 2Cardinal Health, Mansfield, MA, USA

PMD35
A35
STEROID-ELUTING SINUS IMPLANT VERSUS REVISION SURGERY FOR PATIENTS WITH RECURRENT CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP): AN ECONOMIC EVALUATION MODEL
Ernst FR1, Imhoff R1, Minshall M1, DeConde AS2, Manes RP3
1CTI Clinical Trial and Consulting Services, Covington, KY, USA, 2University of California - San Diego, San Diego, CA, USA, 3Yale School of Medicine, New Haven, CT, USA

PMD36
A36
IMPACT OF DISTAL RADIUS STERILE KIT ON PROVIDER BUDGET IN THE USA
Menzie AM1, Vanderkarr M1, Badin MS2, Bhattacharyya S1
1DePuy Synthes, Inc., Raynham, MA, USA, 2Johnson and Johnson Medical Devices, Markham, ON, Canada

PMD37
WITHDRAWN

PMD38
A37
IMPLANTABLE CARDIAC MONITOR COMPARED WITH CONVENTIONAL DIAGNOSTIC FOR UNEXPLAINED SYNCOPE: A COMBINED COST-EFFECTIVENESS AND BUDGET-IMPACT ANALYSIS
Lucchetta RC1, Riveros BS1, Rosim MP2, Holanda P3, Melo M3, Okumura LM3, Gonçalves VF4, Nita ME3
1Federal University of Parana, Curitiba, Brazil, 2University of Sao Paulo, São Paulo, Brazil, 3MAPESolutions, São Paulo, Brazil, 4BIOTRONIK Comercial Médica Ltda., Sao Paulo, Brazil

PMD39
A38
WITHDRAWN

PMD40
A39
WITHDRAWN

PMD41
A40
ECONOMIC IMPACT OF THE USE OF RAPID DEPLOYMENT VALVE REPLACEMENTS IN BRAZIL AND COLOMBIA
Ferreira CN1, Mendoza CF2
1Edwards Lifesciences Latam, São Paulo, Brazil, 2Edwards Lifesciences Latam, Mexico City, Mexico

PMD42
A41
A LITERATURE REVIEW OF TRANSRADIAL VS. TRANSFEMORAL LOWER EXTREMITY PERIPHERAL ARTERY INTERVENTIONS
Igyarto Z, Breitenfeldt M, Martinsen BJ
Cardiovascular Systems, Inc., St. Paul, MN, USA

PMD43
A42
LATEST INSIGHTS ON THE COST EFFICIENCY OF THERAPEUTIC PLASMA EXCHANGE IN TREATING GUILLAIN-BARRE SYNDROME
Dierick K
Terumo BCT, Zaventem, Belgium

PMD44
A43
COMPARATIVE COSTS OF DENSE BREAST CANCER SCREENING AND RECALL: TOMOSYNTHESIS VS. ULTRASOUND
Miller JD1, Bonafede MM1, Pohlman SK2, Troeger KA2
1Truven Health Analytics, an IBM Company, Cambridge, MA, USA, 2Hologic, Inc., Marlborough, MA, USA

PMD45
A44
HEALTHCARE COST ASSOCIATED WITH CARDIAC IMPLANTABLE ELECTRONIC DEVICE INFECTIONS: USING A NATIONAL HEALTH INSURANCE CLAIMS DATABASE
PARK H, Lee S, Jeong J
Medtronic Korea, Seoul, Korea, Republic of (South)

PMD46
WITHDRAWN

PMD47
A45
ULTRAFILTRATION VS. DIURETICS FOR THE TREATMENT OF FLUID OVERLOAD IN HEART FAILURE PATIENTS: A HOSPITAL COST ANALYSIS
Costanzo MR1, Fonarow GC2, Rizzo JA3
1Advocate Health Care, Naperville, IL, USA, 2University of California Los Angeles, Los Angeles, CA, USA, 3Stony Brook University, Stony Brook, NC, USA

PMD48
A46
DISPOSABLE VS. FIBER OPTIC REUSABLE BRONCHOSCOPES FOR HIGH-RISK PROCEDURES: COST-EFFECTIVENESS ANALYSIS (CEA)
Yassin MH, Smith K
Univ of Pittsburgh, Pittsburgh, PA, USA

PMD49
A47
COST EFFECTIVENESS OF ULTRA-VIOLET GERMICIDAL IRRADIATION IN CANADIAN HEALTH REGION
Hall W
University of British Columbia, Vancouver, BC, Canada

PMD50
A48
AN APPRAISAL OF THE QUALITY OF ECONOMIC EVIDENCE IN COST-EFFECTIVENESS AND COST-UTILITY STUDIES IDENTIFIED VIA SYSTEMATIC REVIEW FOR B-TYPE NATRIURETIC PEPTIDE-GUIDED THERAPY IN HEART FAILURE MANAGEMENT PATIENTS
Marupuru S1, Malone DC2
1university of arizona, tucson, AZ, USA, 2University of Arizona, Tucson, AZ, USA

PMD51
A49
COST-EFFECTIVENESS ANALYSIS OF BRONCHIAL THERMOPLASTY VERSUS PHARMACOLOGICAL THERAPIES IN PATIENTS WITH SEVERE ASTHMA IN MEXICO, COLOMBIA AND SPAIN
Figueroa-Lara A1, Aguirre-Perez T2, Tapetado-Rodriguez F3, Puente-Maestu L4, Fernando-Cifuentes L5, Cañas-Arboleda A6, Cangelosi MJ7
1Boston Scientific Mexico, Mexico City, Mexico, 2Instituto Mexicano de Enfermedades Respiratorias, Mexico City, Mexico, 3Boston Scientific Ibérica, Madrid, Spain, 4Hospital Gregorio Marañon,, Madrid, Spain, 5Boston Scientific Colombia, Bogota, Colombia, 6Pontificia Universidad Javeriana, Bogota, Colombia, 7Boston Scientific Corporation, Marlborough, MA, USA

PMD52
WITHDRAWN

PMD53
A50
COST-EFFECTIVENESS AND RETURN ON INVESTMENT OF CONTINUOUS LATERAL ROTATION THERAPY TO PREVENT VENTILATOR-ASSOCIATED PNEUMONIA AND PRESSURE INJURIES IN THE CRITICAL CARE SETTING
Kang SY, DiStefano MJ, Yehia F, Padula WV
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

PMD54
B1
COST - EFFECTIVENESS ANALYSIS OF ULTRASOUND SCREENING FOR THYROID CANCER IN ASYMPTOMATIC POPULATION
Yang H1, Li S2, Guo JJ3, Hu M1
1Sichuan University, Chengdu, China, 2West China Hospital, Sichuan University, Chengdu, China, 3University of Cincinnati, Cincinnati, OH, USA

PMD55
B2
INSULIN DELIVERY SYSTEMS FOR TYPE 1 DIABETES MELLITUS - A COMPARISON USING A DECISION ANALYSIS MODELING APPROACH
Rai P1, Zhang Y1, Stover A2, Iloabuchi C1, Kamal KM3, Chiumente M4
1West Virginia University, School of Pharmacy, Morgantown, WV, USA, 2West Virginia University,School of Pharmacy, Morgantown, WV, USA, 3Duquesne University School of Pharmacy, Pittsburgh, PA, USA, 4Italian Society for Clinical Pharmacy and Therapeutics, Milano, Italy

PMD56
B3
COST-EFFECTIVENESS ANALYSIS OF THE USE OF COBLATION TECHNOLOGY VERSUS MECHANICAL DEBRIDEMENT IN KNEE CHONDROPLASTY - A UK NATIONAL HEALTH SERVICE PERSPECTIVE.
Adeyemi A1, Nherera L2, Trueman P2
1Smith & Nephew, Andover, MA, USA, 2Smith & Nephew, Hull, UK

PMD57
B4
COST-EFFECTIVENESS ANALYSIS OF TRANSCATHETER AORTIC VALVE REPLACEMENT IN INOPERABLE PATIENTS WITH SEVERE AORTIC STENOSIS IN MEXICO
Ferreira CN1, Mendoza CF2, Goodall G3
1Edwards Lifesciences Latam, São Paulo, Brazil, 2Edwards Lifesciences Latam, Mexico City, Mexico, 3Edwards Lifesciences, Nyon, Switzerland

PMD58
B5
COST - EFFECTIVENESS OF THE USE OF THE INSULIN PUMP THERAPY VERSUS DAILY MULTIPLE INJECTIONS IN PATIENTS WITH TYPE 1 DIABETES AT THE MEXICAN INSTITUTE OF SOCIAL SECURITY
Roze S1, Doubova SV2, Gasca R3, Ferreira A2, Barsoe C4, Valencia JE5, Baran J6
1HEVA HEOR, Lyon, France, 2Mexican Institute of Social Security, Mexico, Mexico, 3Medtronic Latin America, Mexico, Mexico, 4Medtronic Global, Northridge, CA, USA, 5Medtronic Latin America, Miami, FL, USA, 6Medtronic Mexico, Mexico, Mexico

PMD59
B6
COST-EFFECTIVENESS OF SERIAL CERVICAL LENGTH SCREENING TO PREVENT PRETERM BIRTH AMONG HIGH-RISK U.S. WOMEN: A DECISION ANALYSIS
Smart M1, Seligman NS2, Prioli KM1, Gray LM2, Pizzi LT1
1Rutgers University, Piscataway, NJ, USA, 2University of Rochester Medical Center, Rochester, NY, USA

PMD60
B7
MODELING THE IMPACT ON CLINICAL UTILITY, PATIENT HARMS, AND COST OF BIOMARKERS FOR THE MANAGEMENT OF INCIDENTALLY DETECTED PULMONARY NODULES
Soneji SS1, Silvestri GA2, Tanner NT2, Piscitello A3, Rinde H4
1Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH, USA, 2Medical University of South Carolina, Charleston, SC, USA, 3EmpiriQA, Long Grove, IL, USA, 4BioBridge Strategies, San Diego, CA, USA

PMD61
B8
ECONOMIC EVALUATION OF THE NERVE CONDUCTION MEASURING DEVICE FOR THE DIAGNOSIS OF PERIPHEAL DIABETIC NEUROPATHY
Soto Molina H1, Diaz-Alvarez O1, Sandoval-Avila M1, Dominguez V1, Sinta Cortes G1, Rodriguez-Mendoza MM2
1HS Estudios Farmacoeconómicos S.A. de C.V., Mexico City, Mexico, 2Independet consultant, Mexico, Mexico

PMD62
B9
COST-EFFECTIVENESS OF BREAST CANCER SCREENING PROGRAM IN THE REPUBLIC OF KAZAKHSTAN
Salikhanov I, Crape BL, Howie P
Nazarbayev University, Astana, Kazakhstan

PMD63
B10
THE COST-EFFECTIVENESS ANALYSIS OF USING CHROMOAGAR FOR ACTIVE SURVEILLANCE OF CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII TO DETERMINE THE DURATION OF CONTACT ISOLATION IN INTENSIVE-CARE UNIT
Chen T1, Lin S2, Shih N1
1Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, 2Kaohsiung Medical University Hospital, Kaohsiung, Taiwan

PMD64
B11
ECONOMIC EVALUATION OF THE ADVANCE LUBRICATH® FOLEY CATHETER TRAY® FOR URINARY CATHETERIZATION OF LONG DURATION
Ruiz Miranda CI1, Rodriguez Mendoza MM2, Goméz Zamesa M1, Sanchez Trejo K2
1Becton Dickinson, Mexico City, Mexico, 2Consultoría en Investigación Farmacéutica, Mexico State, Mexico

PMD65
B12
COST-EFFECTIVENESS OF TRANSCATHETHER AORTIC VALVE IMPLANTATION WITH THE NEW REPOSITIONABLE SELF-EXPANDABLE EVOLUT R VERSUS COREVALVE SYSTEM IN INOPERABLE PATIENTS WITH SEVERE AORTIC STENOSIS IN MEXICO
Guitierrez M1, Muñoz P1, Lemus F1, Flores B1, Gryzbowski E2, Valencia J3
1Pharmamanagement EAS S de RL de CV, Cuidad de México, Mexico, 2Medtronic, Ciudad de México, Mexico, 3Medtronic, Miami, FL, USA

PMD66
B13
ADOPTING A PRAGMATIC METHODOLOGY TO EVALUATE COST-EFFECTIVENESS OF A SIMPLE INSULIN INFUSION DEVICE COMPARED WITH MULTIPLE DAILY INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES ON INSULIN
Wahlqvist P1, Warner J2, Morlock R3
1CeQur (Wales) Ltd, Cardiff, UK, 2CeQur Corporation, Marlborough, MA, USA, 3YourCareChoice, Ann Arbor, MI, USA

PMD67
B14
ECONOMIC EVALUATION OF THE CONFIRMATORY ANTIBODY ASSAY AGAINST HIV-1 AND HIV-2 (GEENIUS™ HIV 1/2 SUPPLEMENTAL ASSAY) AS CONFIRMATORY AND DIFFERENTIATION HIV TEST.
Soto Molina H, Diaz-Alvarez O, Sandoval-Avila M
HS Estudios Farmacoeconómicos S.A. de C.V., Mexico City, Mexico

PMD68
B15
THE COST-EFFECTIVENESS OF A PUBLIC HEALTH NURSE PROGRAM TO SCREEN FOR AMBLYOPIA IN ONTARIO
Asare AO1, Masucci L1, Penner M2
1University of Toronto, Toronto, ON, Canada, 2Holland Bloorview Kids Rehabilitation Hospital, University of Toronto, East York, ON, Canada

PMD69
B16
COST-EFFECTIVENESS OF A TWIN INTERLOCKING DEROTATION AND COMPRESSION SCREW CEPHALOMEDULLARY NAIL (2-SCREW NAIL)* WITH A SINGLE SCREW DEROTATION CEPHALOMEDULLARY NAIL (SINGLE-SCREW NAIL)** IN PATIENTS WITH INTERTROCHANTERIC HIP FRACTURES
Nherera L, Trueman P, Horner A
Smith & Nephew, Hull, UK

PMD70
B17
CERVICAL CANCER SCREENING DECISION MODEL
Vaffis S
University of Arizona, Tucson, AZ, USA

PMD71
B18
HEART RATE VARIABILITY TESTING: COULD IT CHANGE SPENDING FOR RHEUMATOID ARTHRITIS PATIENTS IN THE UNITED STATES? AN EXPLORATORY ECONOMIC ANALYSIS.
Zimmermann M1, Vodicka E1, Holman A2, Garrison LP1
1Consultants in Global Health, Seattle, WA, USA, 2Inmedix, Seattle, WA, USA

PMD72
B19
COMPARING THE COSTS AND OUTCOMES OF A TWIN INTERLOCKING DEROTATION AND COMPRESSION SCREW CEPHALOMEDULLARY NAIL (2-SCREW NAIL)* WITH A SINGLE SCREW CEPHALOMEDULLARY NAIL (SINGLE-SCREW NAIL) IN PATIENTS WITH INTERTROCHANTERIC HIP FRACTURES
Nherera L, Trueman P, Horner A
Smith & Nephew, Hull, UK

PMD73
B20
COST-UTILITY ANALYSIS OF ISTENT TRABECULAR MICRO-BYPASS STENT VERSUS MEDICATIONS ONLY FOR PATIENTS WITH OPEN-ANGLE GLAUCOMA IN COLOMBIA
Ordoñez JE, Ordoñez A, Osorio UM
True Consulting, Envigado, Colombia

PMD74
B21
COST-UTILITY ANALYSIS OF TRABECULAR MICRO-BYPASS STENTS VERSUS LASER TRABECULOPLASTY FOR PATIENTS WITH OPEN-ANGLE GLAUCOMA IN COLOMBIA
Ordoñez JE, Ordoñez A, Osorio UM
True Consulting, Envigado, Colombia

PMD75
B22
COST-UTILITY ANALYSIS OF TWO ULTRASOUND-GUIDED BREAST BIOPSIES: VACUUM-ASSISTED BIOPSY VERSUS CONVENTIONAL CORE NEEDLE BIOPSY
Zhou L1, Liang Y2, Li P2, Ye L1
1Fudan University, Shanghai, China, 2Devicor Medical Device (Shanghai) Co., Ltd, Shanghai, China

PMD76
B23
ACUTE HEALTHCARE UTILIZATION PATTERNS AMONG PEOPLE WITH TYPE 2 DIABETES USING PROFESSIONAL CGM IN THE UNITED STATES.
Sierra JA, Shah M, Vigersky R, Kaufman FR, Flores Z, Gill MS, Stoltenberg LS
Medtronic Diabetes, Northridge, CA, USA

PMD77
B24
ULTRASOUND: A FAST LOW-COST TOOL FOR THE DIAGNOSIS OF RHEUMATOID ARTHRITIS IN A SPECIALIZED CENTER
Santos-Moreno P1, Buitrago-Garcia D2, Villarreal L3, Alvis-Zakzuk N4, Carrasquilla M4, Alvis Guzman N5
1Biomab, bogota, Colombia, 2SIIES investigation and research, Colombia, bogota, Colombia, 3Biomab, center for rheumatoid arthritis, bogota, Colombia, 4Alzak Foundation, Cartagena, Colombia, 5ALZAK Foundation- Universidad De La Costa, Barranquilla, Colombia

MEDICAL DEVICES/DIAGNOSTICS - Patient-Reported Outcomes & Patient Preference Studies
PMD78
B25
USING TIME TRADE-OFF (TTO) SURVEYS TO MEASURE HEALTH UTILITIES ASSOCIATED WITH DIFFERENT URINARY CATHETER INNOVATIONS
Igawa Y1, Krassioukov A2, Averbeck MA3, Madersbacher H4, Lloyd A5, Sørensen J6, Bøgelund M7, Thiruchelvam N8
1The University of Tokyo, Tokyo, Denmark, 2University of British Columbia, Vancouver, Denmark, 3Moinhos de Vento Hospital, Porto Alegre, Brazil, 4Medical University Innsbruck, Innsbruck, Austria, 5Acaster Lloyd Consulting Ltd., London, UK, 6Coloplast A/S, Humlebæk, Denmark, 7Incentive, Holte, Denmark, 8Cambridge University Hospitals NHS Trust, Cambridge, UK

PMD79
B26
THAI ADULTS’ PREFERENCES AND WILLINGNESS-TO-PAY FOR COLORECTAL CANCER SCREENING: A DISCRETE CHOICE EXPERIMENT
Phisalprapa P1, Chaiyakunapruk N2, Ngorsuraches S3, Supakankunti S1
1Faculty of Economics, Chulalongkorn University, Bangkok, Thailand, 2Naresuan University, Phitsanulok, Thailand, 3South Dakota State University, Brookings, SD, USA

PMD80
B27
PATIENT AND CLINICIAN SATISFACTION WITH PHARMACOLOGICAL STRESS AGENTS (PSAS) USED IN SINGLE PHOTON EMISSION COMPUTERIZED TOMOGRAPHY MYOCARDIAL PERFUSION IMAGING (SPECT-MPI)
Shields AL1, Hudgens S2, Spalding J3, Kitt TM3, Ojo O1, Kristy RM4, Mathias A1, Morrissey L1, Litcher-Kelly L1, Houle CR3
1Adelphi Values, Boston, MA, USA, 2Clinical Outcomes Solutions, Tucson, AZ, USA, 3Astellas Pharma Global Development, Inc., Northbrook, IL, USA, 4Astellas Pharma Global Development, Northbrook, IL, USA

MEDICAL DEVICES/DIAGNOSTICS - Health Care Use & Policy Studies
PMD81
B28
A DIGITAL HEALTH PLATFORM TO CREATE PERSONALIZED CARE EXPERIENCES FOR PATIENTS WITH CHRONIC DISEASE
Schultz A1, Mehta J2, Mehta S2
1Partners Healthcare, Brookline, MA, USA, 2KEVA Health, Lexington, MA, USA

PMD82
B29
DETERMINANTS AND PATHWAYS OF REHABILITATION AFTER SURGICAL AORTIC VALVE REPLACEMENT: A POPULATION-BASED, RETROSPECTIVE STUDY WITH ADMINISTRATIVE DATA
Callea G, Borsoi L, Tarricone R
SDA Bocconi School of Management, Milan, Italy

PMD83
B30
ABLATION PROCEDURE USING NEWER RADIOFREQUENCY CATHETERS (THERMOCOOL® SF CATHETER OR THERMOCOOL SMARTTOUCH® CATHETER) VERSUS EARLIER GENERATION THERMOCOOL® CATHETER: A REAL-WORLD COMPARISON OF OUTCOMES USING A US HOSPITAL DATABASE
Goldstein LJ1, Barnow A2, Daskiran M3, Kalsekar I4, Khanna R4
1Johnson & Johnson, Markham, ON, Canada, 2Johnson & Johnson, Diamond Bar, CA, USA, 3Janssen, New Brunswick, NJ, USA, 4Johnson & Johnson Co., New Brunswick, NJ, USA

PMD84
B31
SYSTEMATIC REVIEW OF ENDOBRONCHIAL ULTRASONOGRAPHY WITH GUIDE SHEATH
Kim S1, Jo S1, Lee K1, Ko R1, Kim S1, Kim J2
1National Evidence-based Healthcare Collaborating Agency, Seoul, Korea, Republic of (South), 2Chung-Ang University Hospital, Seoul, Korea, Republic of (South)

PMD85
B32
ABLATION VERSUS ANTIARRHYTHMIC DRUG TREATMENT AMONG PATIENTS WITH ATRIAL FIBRILLATION: A PROPENSITY-MATCHED ANALYSIS
Jarman JW1, March J2, Goldstein LJ3, Liao R4, Kalsekar I5, Khanna R5, Chitnis A6
1Royal Brompton Hospital, London, UK, 2Johnson & Johnson Medical Devices Companies, Irvine, CA, USA, 3Johnson & Johnson, Markham, ON, Canada, 4Janssen R&D US, Raritan, NJ, USA, 5Johnson & Johnson Co., New Brunswick, NJ, USA, 6Johnson & Johnson, New Brunswick, NJ, USA

PMD86
B33
EVALUATION OF CURRENT AND FUTURE PD-(L)1 TESTING REQUIREMENTS IN THE US
Katkhuda R, Carroll ER, Nash C, Carlow D
GfK, New York, NY, USA

PMD87
B34
UNDERSTANDING ECONOMIC MODELS IN MEDICAL DEVICES: AN ORGANIZATION’S PERSPECTIVE
Basu R, Chien H, Alsumali A
Medtronic, Mansfield, MA, USA

PMD88
B35
COVERAGE AND REVIEWS OF MEDICAL DEVICES, GENOMIC AND DIAGNOSTIC TESTING BY US HEALTH PLANS
Brook RA1, Carlisle JA2, Smeeding JE3
1The JeSTARx Group & TPG-NPRT, Newfoundland, NJ, USA, 2The TPG-NPRT, Glastonbury, CT, USA, 3The TPG-NPRT & JeSTARx, Glastonbury, CT, USA

PMD89
B36
WITHDRAWN

PMD90
B37
A SYSTEMATIC REVIEW OF ECONOMIC OUTCOMES ASSOCIATED WITH USE OF TOPICAL INTERVENTIONS FOR TREATMENT OF CHRONIC WOUNDS
Fatoye F, Betts A, Gebrye T, Odeyemi I, Yeowell G
Manchester Metropolitan University, Manchester, UK

PMD91
B38
AMERICAN COLLEGE OF MEDICAL GENETICS (ACMG) RECOMMENDATIONS FOR NEWBORN SCREENING (NBS) FOR BIOTINIDASE DEFICIENCY (BIOT): THE INFLUENCE OF UNCERTAINTY DUE TO MISSING DATA
Kodeih R, Rittenhouse B
MCPHS University, Boston, MA, USA

PMD92
B39
REAL LIFE USE OF DRESSINGS IN THE TREATMENT OF LEG ULCERS AND DIABETIC FOOT ULCERS
Betts A1, Odeyemi I1, Fatoye F1, Yeowell G1, Tadej M2, Lant C2
1Manchester Metropolitan University, Manchester, UK, 2Urgo Medical Ltd, Loughborough, UK

PMD93
B40
REPORTING OF "BENEFIT-RISK" STUDIES FOR MEDICAL DEVICES IN PUBLISHED LITERATURE
Ritchey ME, Hollis KA, Hauber AB, Gilsenan A, Krueger WS
RTI Health Solutions, Research Triangle Park, NC, USA

PMD94
B41
ACCOUNTING FOR KNOWN UNKNOWNS IN THE AMERICAN COLLEGE OF MEDICAL GENETICS (ACMG) RECOMMENDATIONS FOR NBS: POLICY IMPLICATIONS OF ACCOUNTING FOR UNCERTAINTY IN ASSESSMENT IN THE CASE OF MEDIUM CHAIN KETOACYL-COA THIOLASE DEFICIENCY (MCKAT) NEWBORN SCREENING (NBS)
Rittenhouse B
MCPHS University, Boston, MA, USA

PMD95
WITHDRAWN

PMD96
B42
DIFFUSION WITHOUT EVIDENCE: A STUDY ON HIGH-RISK MEDICAL DEVICES
Armeni P1, Torbica A2, Tarricone R1, Drummond M3
1SDA Bocconi School of Management, Milan, Italy, 2Bocconi University, Milano, Italy, 3University of York, Heslington, York, UK

PMD97
B43
REIMBURSEMENT LANDSCAPE FOR MOLECULAR TESTING IN NON-SMALL CELL LUNG CANCER (NSCLC) IN THE UNITED STATES
Nellesen D1, Patton C1, Mutebi A2, Culver KW2
1Analysis Group, Inc, Menlo Park, CA, USA, 2Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

PMD98
B44
FINANCIAL BENEFIT OF A NEW ULTRASONIC ENERGY DEVICE IN OPEN AND LAPAROSCOPIC PROCEDURES
Park HJ, Kwak M
Johnson and Johnson Medical, Seoul, Korea, Republic of (South)

PMD99
B45
PATELLA FRACTURE: COST, COMPLICATIONS AND TREATMENTS IN THE COMMERCIALLY-INSURED POPULATION
Vanderkarr M1, Chitnis AS2, Sparks C3, Holy CE2
1DePuy Synthes, Inc., Raynham, MA, USA, 2Johnson & Johnson, New Brunswick, NJ, USA, 3DePuy Synthes Inc., West Chester, PA, USA

PMD100
B46
SEPTIC REVISION OF ALL KNEE COMPONENTS FOLLOWING TOTAL KNEE ARTHROPLASTY: TYPE AND PAYMENTS FOR CARE, AND INCIDENCE OF 1-YEAR RE-INFECTION AND AMPUTATION.
Lerner J1, Chitnis AS2, Holy CE2
1Johnson & Johnson Medical Devices, Raynham, MA, USA, 2Johnson & Johnson, New Brunswick, NJ, USA

PMD101
C1
HEALTH CARE RESOURCE UTILIZATION AND DIRECT MEDICAL COSTS AMONG PATIENTS RECEIVING TREATMENT FOR PELVIC FRACTURES
Chitnis AS1, Childers C2, Vanderkarr M3, Sparks C4, Folly E1, Holy CE1
1Johnson & Johnson, New Brunswick, NJ, USA, 2DePuy Synthes, West Chester, PA, USA, 3DePuy Synthes, Inc., Raynham, MA, USA, 4DePuy Synthes Inc., West Chester, PA, USA

PMD102
C2
COST AND SHELF-LIFE IMPLICATIONS OF PATHOGEN-REDUCED PLATELETS: A HOSPITAL BUDGET IMPACT MODEL
Prioli KM1, Lyons NM2, Karp JK3, Herman JH3, Pizzi LT1
1Rutgers University, Piscataway, NJ, USA, 2Thomas Jefferson University, Philadelphia, PA, USA, 3Thomas Jefferson University Hospital, Philadelphia, PA, USA

PMD103
C3
CLINICAL AND ECONOMIC IMPACT OF SWITCHING FROM NEGATIVE- OR NEUTRAL DISPLACEMENT NEEDLELESS CONNECTORS TO POSITIVE DISPLACEMENT NEEDLELESS CONNECTORS IN CENTRAL VASCULAR ACCESS SETTINGS
Gala S1, Erdal EP2, Tuttle R3
1BD, Franklin Lakes, NJ, USA, 2Becton Dickinson and Co., Franklin Lakes, NJ, USA, 3Becton Dickinson and Co., Sandy, UT, USA

PMD104
C4
REAL-WORLD INFECTION AND NON-UNION RATES ASSOCIATED WITH CLOSED OR OPEN FRACTURES OF THE TIBIAL SHAFT REQUIRING OPEN REDUCTION AND INTERNAL FIXATION
Chitnis AS1, Vanderkarr M2, Sparks C3, McGlohorn J4, Holy CE1
1Johnson & Johnson, New Brunswick, NJ, USA, 2DePuy Synthes, Inc., Raynham, MA, USA, 3DePuy Synthes Inc., West Chester, PA, USA, 4DePuy Synthes, West Chester, PA, USA

PMD105
C5
FEMORAL SHAFT FRACTURES: TREATMENT COSTS AND COMPLICATION RISKS – A CLAIMS DATABASE ANALYSIS
Holy CE1, Vanderkarr M2, Chitnis AS1, Sparks C3
1Johnson & Johnson, New Brunswick, NJ, USA, 2DePuy Synthes, Inc., Raynham, MA, USA, 3DePuy Synthes Inc., West Chester, PA, USA

PMD106
C6
COMPLICATIONS, HEALTH CARE RESOURCE UTILIZATION AND COSTS ASSOCIATED WITH TYPE III OPEN FRACTURES OF THE TIBIAL SHAFT REQUIRING OPEN REDUCTION AND INTERNAL FIXATION
Chitnis AS1, Vanderkarr M2, Sparks C3, McGlohorn J4, Holy CE1
1Johnson & Johnson, New Brunswick, NJ, USA, 2DePuy Synthes, Inc., Raynham, MA, USA, 3DePuy Synthes Inc., West Chester, PA, USA, 4DePuy Synthes, West Chester, PA, USA

PMD107
C7
TRENDS IN UTILIZATION OF ENDOVASCULAR ARTERIAL REVASCULARIZATION MODALITIES BELOW THE KNEE IN GERMANY 2009-16
Geisler BP1, Weber SA2, Pietzsch M3, Pietzsch JB1, Zeller T4
1Wing Tech Inc., Menlo Park, CA, USA, 2Cellogic GmbH, Berlin, Germany, 3Wingtec GmbH, Karlsruhe, Germany, 4Universitaets-Herzzentrum Freiburg-Bad Krozingen, Bad Krozingen, Germany

PMD108
C8
SURGICAL PROCEDURES FOR KNEE OSTEOARTHRITIS- VOLUME AND COSTS AMONG THE COMMERCIALLY-INSURED PATIENTS IN THE UNITED STATES
Holy CE1, Chitnis AS1, Escarpeta-Soriano J2, Vanderkarr M3, Sparks C4
1Johnson & Johnson, New Brunswick, NJ, USA, 2DePuy Synthes, West Chester, PA, USA, 3DePuy Synthes, Inc., Raynham, MA, USA, 4DePuy Synthes Inc., West Chester, PA, USA

PMD109
C9
A HOSPITAL BUDGET IMPACT MODEL TO ESTIMATE THE IMPACT ASSOCIATED WITH PHASIX™ AND PHASIX™ ST MESH VERSUS STRATTICETM MATRIX IN COMPLEX VENTRAL HERNIA REPAIR PROCEDURES
Hofstetter S1, Hutcheson R2, Gultyaev D3, Stern L4, Tripodi D5, Corral M6
1NYU Langone, New York, NY, USA, 2Analytica Laser, Montreal, QC, Canada, 3LA-SER Analytica, Lorrach, Germany, 4Analytica Laser, New York, NY, USA, 5BD, Warwick, RI, USA, 6BD, Murray Hill, NJ, USA

PMD110
C10
WITHDRAWN

PMD111
C11
HOSPITALIZATION COSTS FOR TREATMENT OF PERIPROSTHETIC FRACTURES OF THE KNEE USING MEDICARE CLAIMS AND A HOSPITAL BILLING DATA IN THE UNITED STATES
Chitnis AS1, Smith B2, Vanderkarr M3, Sparks C4, Holy CE1
1Johnson & Johnson, New Brunswick, NJ, USA, 2DePuy Synthes, West Chester, PA, USA, 3DePuy Synthes, Inc., Raynham, MA, USA, 4DePuy Synthes Inc., West Chester, PA, USA

PMD112
C12
INTERVENTIONAL RADIOLOGY TO BEDSIDE PERIPHERALLY INSERTED CENTRAL CATHETER PLACEMENT: A U.S. HOSPITAL COST ANALYSIS
Kara R1, Lemon R2, Hollmann S3
1Becton Dickinson & Co., Salt Lake City, UT, USA, 2Bard Access Systems, Salt Lake City, UT, USA, 3Cornerstone Research Group Inc., Burlington, ON, Canada

PMD113
C13
A RETROSPECTIVE ANALYSIS OF TACK USE WITH PROGRIP™ LAPAROSCOPIC SELF-FIXATING MESH AND 3DMAX™ MESH IN OUTPATIENT HOSPITAL INGUINAL HERNIA REPAIR PROCEDURES
Tripodi D1, Zhang X2, Wan Y2, Berhane I2, Corral M2
1BD, Warwick, RI, USA, 2BD, Murray Hill, NJ, USA

PMD114
C14
IMPACT OF THE HITECH ACT’S INCENTIVE PROGRAM ON THE ADOPTION OF DRUG-DRUG INTERACTION ALERTS AND ELECTRONIC PRESCRIBING IN THE AMBULATORY CARE SETTING
Malhani MA1, Maneno MK2, Ettienne EB1, Wingate LT1
1Howard University, Washington, DC, USA, 2Howard University College of Pharmacy, Washington, DC, USA

PMD115
C15
IMPACT OF URINE DRUG TESTING AMONGST PATIENTS AT INCREASED RISK OF DRUG-DRUG INTERACTIONS
Schrecker J1, Hild C1, Robert T1, Layton AJ2, Tang J3, Arnold RJ3
1Aegis Sciences Corporation, Nashville, TN, USA, 2Navigant Consulting, Inc., San Francisco, TN, USA, 3Navigant Consulting, Inc., San Francisco, CA, USA

PMD116
C16
SYSTEMATIC REVIEW ON CLINICAL AND HEALTH ECONOMIC BENEFIT OF USING SAFE BLOOD DRAWING DEVICE
Xu H1, Jiang L2, Tao L3
1Becton, Dickinson and Company, Shanghai, China, 2Sun Yat-sen University, Guangzhou, China, 3Sun Yat-Sen University, Guangzhou, China

PMD117
C17
DEMOGRAPHIC VARIATION OF HEPATITIS C VIRUS (HCV) PREVALENCE IN THE US: RESULTS FROM THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY 2009 – 2016
Ozigbu CE1, Adeyinka DA2, Olakunde BO3, Olatosi BA1
1University of South Carolina, Columbia, SC, USA, 2University of Saskatchewan, Saskatoon, SK, Canada, 3University of Nevada, Las vegas, NV, USA

PMD118
WITHDRAWN

PMD119
C18
A SYSTEMATIC ASSESSMENT OF BUDGET IMPACT MODELS FOR MEDICAL DEVICES
Basu R, Alsumali A
Medtronic, Mansfield, MA, USA

PMD120
C19
FEMININE HYGIENE PRODUCT USE AND AWARENESS AMONG YOUNG US ADULTS
Rai P1, Shah D1, Kelly K2
1West Virginia University, School of Pharmacy, Morgantown, WV, USA, 2West Virginia University, Morgantown, WV, USA

PMD121
C20
ASSESSMENT OF THE USE OF PHARMACOGENETICS IN THE DIAGNOSIS AND TREATMENT OF SCHIZOPHRENIA: RESULTS FROM A SURVEY OF PSYCHIATRISTS
Desmond S1, Gavaghan M1, Howe T2
1GfK, Waltham, MA, USA, 2GfK UK, London, UK

PMD122
C21
DEVELOPMENT OF A COORDINATED REGISTRY NETWORK FOR WOMEN'S HEALTH TECHNOLOGIES
Baird CE1, Marinac-Dabic D2, Darbouze F3, Lang L4, Dumont D5, Sedrakyan A1
1Weill Cornell Medicine, New York, NY, USA, 2U.S. Food and Drug Administration, Silver Spring, MD, USA, 3Office of the National Coordinator for Health Information Technology (ONC), Washington, DC, USA, 4National Library of Medicine (NLM), Bethesda, MD, USA, 5U.S. Food and Drug Administration, Division of Epidemiology, Office of Surveillance and Biometrics, Silver Spring, MD, USA

Contact ISPOR @ info@ispor.org | View Legal Disclaimer
© 2018 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.